{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T19:50:43Z","timestamp":1772826643533,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T00:00:00Z","timestamp":1663632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T00:00:00Z","timestamp":1663632000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s00277-022-04972-y","type":"journal-article","created":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T05:03:48Z","timestamp":1663650228000},"page":"2453-2460","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Usefulness of anti-factor VIII IgG ELISA in acquired hemophilia A follow-up"],"prefix":"10.1007","volume":"101","author":[{"given":"Albain","family":"Chansavang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aur\u00e9lien","family":"Philippe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ines","family":"Bozinovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalil","family":"Ben Hadj Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Smadja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Helley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc","family":"Darnige","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3946-2312","authenticated-orcid":false,"given":"Laetitia","family":"Mauge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,20]]},"reference":[{"key":"4972_CR1","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.3324\/haematol.2019.230771","volume":"105","author":"A Tiede","year":"2020","unstructured":"Tiede A, Collins P, Knoebl P et al (2020) International recommendations on the diagnosis and treatment of acquired hemophilia A. Haematologica 105:1791\u20131801. https:\/\/doi.org\/10.3324\/haematol.2019.230771","journal-title":"Haematologica"},{"key":"4972_CR2","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1111\/j.1538-7836.2012.04654.x","volume":"10","author":"P Knoebl","year":"2012","unstructured":"Knoebl P, Marco P, Baudo F et al (2012) Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). J Thromb Haemost JTH 10:622\u2013631. https:\/\/doi.org\/10.1111\/j.1538-7836.2012.04654.x","journal-title":"J Thromb Haemost JTH"},{"key":"4972_CR3","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1160\/TH14-12-1062","volume":"114","author":"P Batty","year":"2015","unstructured":"Batty P, Moore GW, Platton S et al (2015) Diagnostic accuracy study of a factor VIII ELISA for detection of factor VIII antibodies in congenital and acquired haemophilia A. Thromb Haemost 114:804\u2013811. https:\/\/doi.org\/10.1160\/TH14-12-1062","journal-title":"Thromb Haemost"},{"key":"4972_CR4","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1182\/blood-2014-07-587089","volume":"125","author":"A Tiede","year":"2015","unstructured":"Tiede A, Klamroth R, Scharf RE et al (2015) Prognostic factors for remission of and survival in acquired hemophilia A (AHA): results from the GTH-AH 01\/2010 study. Blood 125:1091\u20131097. https:\/\/doi.org\/10.1182\/blood-2014-07-587089","journal-title":"Blood"},{"key":"4972_CR5","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1055\/a-1223-3353","volume":"40","author":"A Tiede","year":"2020","unstructured":"Tiede A, Alberio L (2020) The art of detecting antibodies against factor VIII. Hamostaseologie 40:485\u2013490. https:\/\/doi.org\/10.1055\/a-1223-3353","journal-title":"Hamostaseologie"},{"key":"4972_CR6","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1055\/s-0033-1334867","volume":"39","author":"AB Federici","year":"2013","unstructured":"Federici AB, Budde U, Castaman G et al (2013) Current diagnostic and therapeutic approaches to patients with acquired von Willebrand syndrome: a 2013 update. Semin Thromb Hemost 39:191\u2013201. https:\/\/doi.org\/10.1055\/s-0033-1334867","journal-title":"Semin Thromb Hemost"},{"key":"4972_CR7","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1055\/s-0034-1390004","volume":"40","author":"A Tiede","year":"2014","unstructured":"Tiede A, Werwitzke S, Scharf R (2014) Laboratory Diagnosis of acquired hemophilia A: Limitations, consequences, and challenges. Semin Thromb Hemost 40:803\u2013811. https:\/\/doi.org\/10.1055\/s-0034-1390004","journal-title":"Semin Thromb Hemost"},{"key":"4972_CR8","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1055\/s-0029-1245110","volume":"35","author":"S Kitchen","year":"2009","unstructured":"Kitchen S, Jennings I, Preston F et al (2009) Interlaboratory variation in factor VIII: C inhibitor assay results is sufficient to influence patient management: data from the UK National Quality External Assessment Scheme for Blood Coagulation. Semin Thromb Hemost 35:778\u2013785. https:\/\/doi.org\/10.1055\/s-0029-1245110","journal-title":"Semin Thromb Hemost"},{"key":"4972_CR9","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1111\/jth.13304","volume":"14","author":"S Werwitzke","year":"2016","unstructured":"Werwitzke S, Geisen U, Nowak-G\u00f6ttl U et al (2016) Diagnostic and prognostic value of factor VIII binding antibodies in acquired hemophilia A: data from the GTH-AH 01\/2010 study. J Thromb Haemost JTH 14:940\u2013947. https:\/\/doi.org\/10.1111\/jth.13304","journal-title":"J Thromb Haemost JTH"},{"key":"4972_CR10","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/ajh.24777","volume":"92","author":"R Kruse-Jarres","year":"2017","unstructured":"Kruse-Jarres R, Kempton CL, Baudo F et al (2017) Acquired hemophilia A: updated review of evidence and treatment guidance. Am J Hematol 92:695\u2013705. https:\/\/doi.org\/10.1002\/ajh.24777","journal-title":"Am J Hematol"},{"key":"4972_CR11","doi-asserted-by":"publisher","first-page":"566","DOI":"10.3324\/haematol.2008.001743","volume":"94","author":"A Huth-K\u00fchne","year":"2009","unstructured":"Huth-K\u00fchne A, Baudo F, Collins P et al (2009) International recommendations on the diagnosis and treatment of patients with acquired hemophilia A. Haematologica 94:566\u2013575. https:\/\/doi.org\/10.3324\/haematol.2008.001743","journal-title":"Haematologica"},{"key":"4972_CR12","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1182\/blood-2006-06-029850","volume":"109","author":"PW Collins","year":"2007","unstructured":"Collins PW, Hirsch S, Baglin TP et al (2007) Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors\u2019 Organisation. Blood 109:1870\u20131877. https:\/\/doi.org\/10.1182\/blood-2006-06-029850","journal-title":"Blood"},{"key":"4972_CR13","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/j.1365-2516.2007.01450.x","volume":"13","author":"MA Sahud","year":"2007","unstructured":"Sahud MA, Pratt KP, Zhukov O et al (2007) ELISA system for detection of immune responses to FVIII: a study of 246 samples and correlation with the Bethesda assay. Haemophilia 13:317\u2013322. https:\/\/doi.org\/10.1111\/j.1365-2516.2007.01450.x","journal-title":"Haemophilia"},{"key":"4972_CR14","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1182\/blood-2016-06-720086","volume":"129","author":"A Cannav\u00f2","year":"2017","unstructured":"Cannav\u00f2 A, Valsecchi C, Garagiola I et al (2017) Nonneutralizing antibodies against factor VIII and risk of inhibitor development in severe hemophilia A. Blood 129:1245\u20131250. https:\/\/doi.org\/10.1182\/blood-2016-06-720086","journal-title":"Blood"},{"key":"4972_CR15","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1046\/j.1365-2141.1996.d01-1705.x","volume":"93","author":"F Dazzi","year":"1996","unstructured":"Dazzi F, Tison T, Vianello F et al (1996) High incidence of anti-FVIII antibodies against non-coagulant epitopes in haemophilia A patients: a possible role for the half-life of transfused FVIII. Br J Haematol 93:688\u2013693. https:\/\/doi.org\/10.1046\/j.1365-2141.1996.d01-1705.x","journal-title":"Br J Haematol"},{"key":"4972_CR16","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1423-0410.1994.tb00269.x","volume":"66","author":"W Mondorf","year":"1994","unstructured":"Mondorf W, Ehrenforth S, Vigh Z et al (1994) Screening of F.VIII: C antibodies by an enzyme-linked immunosorbent assay. Vox Sang 66:8\u201313. https:\/\/doi.org\/10.1111\/j.1423-0410.1994.tb00269.x","journal-title":"Vox Sang"},{"key":"4972_CR17","first-page":"1045","volume":"85","author":"AN Blanco","year":"2000","unstructured":"Blanco AN, Peirano AA, Grosso SH et al (2000) An ELISA system to detect anti-factor VIII antibodies without interference by lupus anticoagulants. Preliminary data in hemophilia A patients. Haematologica 85:1045\u20131050","journal-title":"Haematologica"},{"key":"4972_CR18","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1046\/j.1365-2257.1999.00194.x","volume":"21","author":"PG Martin","year":"1999","unstructured":"Martin PG, Sukhu K, Chambers E, Giangrande PL (1999) Evaluation of a novel ELISA screening test for detection of factor VIII inhibitory antibodies in haemophiliacs. Clin Lab Haematol 21:125\u2013128. https:\/\/doi.org\/10.1046\/j.1365-2257.1999.00194.x","journal-title":"Clin Lab Haematol"},{"key":"4972_CR19","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1182\/blood.V82.6.1767.1767","volume":"82","author":"D Scandella","year":"1993","unstructured":"Scandella D, Mattingly M, Prescott R (1993) A recombinant factor VIII A2 domain polypeptide quantitatively neutralizes human inhibitor antibodies that bind to A2. Blood 82:1767\u20131775","journal-title":"Blood"},{"key":"4972_CR20","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1046\/j.1365-2516.2001.00456.x","volume":"7","author":"J Klinge","year":"2001","unstructured":"Klinge J, Auerswald G, Budde U et al (2001) Detection of all anti-factor VIII antibodies in haemophilia A patients by the Bethesda assay and a more sensitive immunoprecipitation assay. Haemoph Off J World Fed Hemoph 7:26\u201332. https:\/\/doi.org\/10.1046\/j.1365-2516.2001.00456.x","journal-title":"Haemoph Off J World Fed Hemoph"},{"key":"4972_CR21","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/hae.13752","volume":"25","author":"M Trossaert","year":"2019","unstructured":"Trossaert M, Graveleau J, Thiercelin-Legrand M-F et al (2019) The factor VIII:C\/VWF: Ag ratio as a useful tool to predict relapse in patients with acquired haemophilia A: a retrospective cohort study. Haemoph Off J World Fed Hemoph 25:527\u2013534. https:\/\/doi.org\/10.1111\/hae.13752","journal-title":"Haemoph Off J World Fed Hemoph"},{"key":"4972_CR22","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1182\/blood-2015-09-672774","volume":"127","author":"A Tiede","year":"2016","unstructured":"Tiede A, Hofbauer CJ, Werwitzke S et al (2016) Anti-factor VIII IgA as a potential marker of poor prognosis in acquired hemophilia A: results from the GTH-AH 01\/2010 study. Blood 127:2289\u20132297. https:\/\/doi.org\/10.1182\/blood-2015-09-672774","journal-title":"Blood"},{"key":"4972_CR23","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1055\/s-0029-1245109","volume":"35","author":"L Tay","year":"2009","unstructured":"Tay L, Duncan E, Singhal D et al (2009) Twelve years of experience of acquired hemophilia A: trials and tribulations in South Australia. Semin Thromb Hemost 35:769\u2013777. https:\/\/doi.org\/10.1055\/s-0029-1245109","journal-title":"Semin Thromb Hemost"},{"key":"4972_CR24","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1182\/blood.2020006315","volume":"137","author":"P Knoebl","year":"2021","unstructured":"Knoebl P, Thaler J, Jilma P et al (2021) Emicizumab for the treatment of acquired hemophilia A. Blood 137:410\u2013419. https:\/\/doi.org\/10.1182\/blood.2020006315","journal-title":"Blood"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-022-04972-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-022-04972-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-022-04972-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T05:06:21Z","timestamp":1665119181000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-022-04972-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,20]]},"references-count":24,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["4972"],"URL":"https:\/\/doi.org\/10.1007\/s00277-022-04972-y","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,20]]},"assertion":[{"value":"28 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}